New Federal Bill Aims to Set THC Rules Before Hemp Ban Hits

August 16, 2026

Photo by Hagar Lotte Geyer via Unsplash.

Introduction

The date to circle is November 12, 2026. That is when a provision buried in the 2026 Appropriations Act flips the legal definition of hemp on its head, and unless Congress acts before then, a huge swath of the products currently sitting on gas station counters and dispensary shelves become federally illegal overnight. Section 781 replaces the 2018 Farm Bill's delta-9 THC threshold with a total THC standard, hemp must test at or below 0.3% total THC on a dry-weight basis, a calculation that folds in THCA and other cannabinoids that convert to THC when heated. Layered on top of that is a hard cap of 0.4 milligrams of total THC per container for any finished product, a ceiling so restrictive that industry estimates suggest it would eliminate roughly 95% of hemp products currently sold in the United States. The stakes are not small money, the U.S. hemp industry is estimated at roughly $28 billion, supporting hundreds of thousands of jobs and generating significant state tax revenue. Several bills have been introduced to fix or replace Section 781, but none has cleared even one chamber, let alone reached the president's desk. The Lawful Hemp Protection Act, introduced by Reps. Andy Barr and Byron Craig, is the latest and arguably most serious attempt to build a permanent regulatory framework, replacing the 0.4 milligram cap with a 1% total THC limit measured by dry weight, handing the FDA direct authority over hemp products, banning marketing to minors, and establishing a fee structure that includes a 5% excise tax on most products and a dose-based tax on beverages. But it faces a crowded field of competing fixes, and the clock is running.

The Deadline Driving This Bill

Photo by Botond Czapp via Pexels.

The date to circle is November 12, 2026. That's when a provision buried in the 2026 Appropriations Act flips the legal definition of hemp on its head, and unless Congress acts before then, a huge swath of the products currently sitting on gas station counters and dispensary shelves become federally illegal overnight.

Here's how we got here. On November 12, 2025, Congress passed the appropriations package containing Section 781, and President Trump signed it into law. Rather than triggering immediately, lawmakers built in a one-year runway, pushing the effective date out exactly a year to give the industry time to adjust, or to give Congress time to write something better. Section 781 replaces the 2018 Farm Bill's delta-9 THC threshold with a total THC standard: hemp must test at or below 0.3% total THC on a dry-weight basis, a calculation that folds in THCA and other cannabinoids that convert to THC when heated, not just delta-9 alone. Layered on top of that is a hard cap of 0.4 milligrams of total THC per container for any finished product.

That 0.4 mg number is the part rattling the industry. It's not a percentage that scales with product size or serving count -- it's a flat ceiling per package. A gummy, a bottle of tincture, a can of hemp-derived beverage, a jar of smokable flower: all of it would need to fit under that same razor-thin allowance regardless of format. Industry trade groups have run the math and come back with a grim consensus, estimating the cap would eliminate somewhere around 95% of the hemp products currently sold in the United States, including virtually the entire smokable hemp flower category and most THCA-based products that have carried the legal cannabinoid market since 2018.

The stakes are not small money. MJBizDaily pegs the U.S. hemp industry at roughly $28 billion, and other estimates run as high as $40 billion when you account for the full supply chain -- farmers, extractors, packagers, retailers, and the beverage and wellness brands that have built entire product lines around hemp-derived cannabinoids in the post-Farm Bill years.

And right now, nothing meant to fix or replace Section 781 has moved past committee. Several bills have been introduced, but none has cleared even one chamber, let alone reached the president's desk. That leaves the industry watching a clock that doesn't stop, with a compliance deadline that arrives automatically whether or not Congress finds consensus in time.

What the Lawful Hemp Protection Act Actually Does

Photo by Saul Rivera via Pexels.

The bill runs 60 pages, and most of the substance is in how it redefines what counts as legal hemp in the first place. Right now, the operative federal limit for many hemp-derived products comes down to a 0.4 milligram per container cap on total THC, a threshold that's forced companies making gummies, beverages, and tinctures into contortions to stay compliant while still delivering a noticeable effect. The Lawful Hemp Protection Act throws that number out and replaces it with a 1% total THC limit measured by dry weight on the finished product, not the raw flower going into it. That's a meaningful shift in how compliance gets calculated, and it would give manufacturers a workable ceiling instead of a milligram count that made federally legal edibles nearly indistinguishable from placebos.

The bill also hands the FDA direct authority over regulating hemp products, treating them more like the agency treats food, supplements, and other ingestible consumer goods rather than leaving oversight scattered across USDA hemp farming rules and a patchwork of state THC caps. That's a structural change as much as a numerical one -- it puts one agency in charge of labeling, manufacturing standards, and safety enforcement for the products people are actually buying off shelves.

On the consumer-protection side, the bill bans marketing hemp products to kids and would restrict sales to adults 21 and older nationwide, mirroring the age gate most states already apply to alcohol and marijuana. It also requires regulated hemp products to be domestically produced, which would reshape supply chains for companies currently sourcing biomass or finished goods from overseas.

The synthetic cannabinoid provision is where the bill gets most specific. It explicitly excludes any cannabinoid the cannabis plant can't produce naturally, naming HHC, THC-O-acetate, and THCP as banned synthetic analogs by name, while giving USDA and HHS the authority to add new compounds to that banned list as chemists find new ways around existing rules.

Who Pays: The Fee Structure

THC beverage sales more than doubled, jumping from $102 million to $239 million over the 52 weeks ending June 27, 2026, highlighting rapid growth in the hemp-derived beverage market.

The bill's money mechanics matter as much as its regulatory scaffolding, because they tell you how Congress actually views this industry. For most hemp-derived consumable products moving across state lines, the fee lands at 5% of retail price -- a straightforward excise structure similar to what states already apply to alcohol or, in some cases, adult-use cannabis. Gummies, tinctures, capsules, and other ingestible hemp products would all fall under that flat 5% rate, collected at the point of interstate sale.

Beverages get their own carve-out, and it's a telling one. Instead of a percentage-of-price fee, hemp drinks would be taxed at 5 cents per milligram of THC in the product. A 5mg seltzer and a 10mg canned cocktail wouldn't pay the same rate -- the tax scales directly with dose rather than shelf price. That's a meaningfully different approach, and it suggests lawmakers or their staff spent real time thinking about how this category actually works, since a $6 six-pack with 25mg total THC across five cans behaves nothing like a $6 bag of gummies with 100mg packed into ten pieces.

The separate treatment isn't arbitrary. THC beverages have gone from a novelty at hemp expos to a genuine retail category in the space of about two years, and the growth curve backs that up: NielsenIQ data cited by Forbes put THC beverage sales at $239 million for the 52 weeks ending June 27, 2026, up 135% from the year before. That's not incremental growth from a niche product line -- that's a category doubling and then some, fast enough that beverage distributors, grocery chains, and even some beer wholesalers have started paying attention to shelf placement and taxation questions that didn't exist in any serious way five years ago.

Put those two pieces together -- a flat consumer-goods fee for most products, a dose-based fee for the fastest-growing segment -- and the message from Capitol Hill is fairly clear. This isn't legislation written to squeeze hemp products out of existence through punitive taxation, nor is it an attempt to quietly close the door on intoxicating hemp entirely. It reads like lawmakers accepting that hemp-derived THC products are now a durable retail category, worth building a permanent fee collection system around rather than legislating out of existence. Whether state regulators and existing cannabis operators see it the same way is a separate question, and one worth watching as the bill moves through committee.

A Crowded Field of Competing Fixes

Photo by Samuel Schroth via Unsplash.

Barr and Craig aren't operating in a vacuum. At least four other bills currently sitting in Congress attempt to solve the same hemp THC problem, and each takes a genuinely different approach, which is part of why nothing has moved yet. Rep. Morgan Griffith's HEMP Act, HR 7212, introduced January 22, 2026, would push most hemp products into the dietary supplement category under FDA oversight, applying a 1% total THC threshold that lands close to what Barr and Craig have proposed. The overlap between these two bills is close enough that some Hill staffers reportedly see them as candidates for merging rather than competing for the same slot on a committee calendar.

Rep. Nancy Mace has taken the opposite approach. Her American Hemp Protection Act, HR 6209, filed November 17, 2025, is a one-move bill: strike Section 781 entirely and leave the original 2018 Farm Bill definition of hemp in place, with no new potency cap and no new consumer protections layered on top. It's the version of this fight that hemp beverage and gummy manufacturers have been lobbying hardest for, since it preserves the status quo that let the intoxicating hemp market grow into an estimated multibillion-dollar industry in the first place.

Then there's the bill that simply buys time. HR 7010 and its Senate companion, S. 3686, would delay implementation of the Section 781 restrictions rather than rewrite them, and as of July 20 that legislation remains stuck in committee with no floor action scheduled. It's the least ambitious of the bunch, and its stall is a useful data point on how little urgency exists to move any hemp fix quickly.

A fifth track comes from an unusual bipartisan pairing: Sens. Amy Klobuchar and Rand Paul have floated a bill that would let individual states opt out of federal hemp restrictions altogether, effectively punting the whole question to state legislatures already writing their own THC-per-serving caps.

What sets the Barr-Craig bill apart from this pile isn't just its content -- it's reported backing from the White House, plus Craig's position as the top Democrat on House Agriculture, a seat that gives her real leverage over whichever version of a hemp framework eventually reaches markup.

Conclusion

The Lawful Hemp Protection Act is the most serious attempt yet to build a permanent framework for hemp-derived THC products, but it is far from a done deal. The bill has White House backing and the reported support of key committee leadership, but it faces a crowded field of competing fixes that take genuinely different approaches, from outright repeal of Section 781 to simple delay to state-by-state opt-outs. That fragmentation is part of why nothing has moved past committee yet, and with the November 12 deadline approaching, the industry is watching a clock that does not stop. The fee structure in the bill, 5% on most products and a dose-based tax on beverages, reads like lawmakers accepting that hemp-derived THC products are now a durable retail category worth building a permanent system around rather than legislating out of existence. But whether state regulators and existing cannabis operators see it the same way is a separate question, and one worth watching as the bill moves through committee. The rapid growth of the THC beverage category, more than doubling to $239 million in annual sales, has made the question of how to tax and regulate these products impossible to ignore. For the broader hemp industry, the stakes are clear: a 0.4 milligram cap means near-total elimination of the product category that has driven growth since 2018, while a 1% threshold with FDA oversight offers a path forward. The difference between those outcomes will be decided in the coming weeks and months, and the outcome depends on whether Congress can coalesce around a single approach before the deadline forces the issue.